Alex Karpa reports on the optimism surrounding an experimental treatment for Alzheimer's.

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

We examined the association between vulnerability to financial exploitation and thickness of a brain region called the ...

Researchers are experimenting with memory-based activities as a way to treat Alzheimer's, saying it can boost cognitive neurons needed to fight the disease.

Pioneering musicians are trialling a radical approach that takes treatment beyond medicine – and could save the NHS millions ...

It is now known that, for most men, erectile dysfunction is caused by physical problems, usually related to the blood supply of the penis. Many advances have occurred in both diagnosis and treatment ...